MedPath

Formoterol fumarate

These highlights do not include all the information needed to use FORMOTEROL FUMARATE INHALATION SOLUTION safely and effectively. See full prescribing information for FORMOTEROL FUMARATE INHALATION SOLUTION. FUMARATE inhalation solution, for respiratory use Initial U.S. Approval: 2001

Approved
Approval ID

9786f3e2-4265-4246-9999-f73cd6b33fc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Formoterol fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-8813
Application NumberANDA091141
Product Classification
M
Marketing Category
C73584
G
Generic Name
Formoterol fumarate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 13, 2021
FDA Product Classification

INGREDIENTS (5)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
FORMOTEROL FUMARATEActive
Quantity: 20 ug in 2 mL
Code: W34SHF8J2K
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Formoterol fumarate - FDA Drug Approval Details